Article
Inhibition of Bruton’s tyrosine kinase reduces NF-kB and NLRP3 inflammasome activity preventing insulin resistance and microvascular disease
2019-08-28
Abstract excerpt
Activation of inflammatory pathways in myeloid cells initiates insulin resistance leading to the development of type-2 diabetes and microvascular disease. Currently, there are no therapies available that target inflammation in T2D or microvascular disease. In the present study we investigate if Bruton’s tyrosine kinase (BTK) may represent a novel therapeutic target using the FDA approved medication ibrutinib. Ibru...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ce75489f-db2d-5540-ae25-297e47397bc3
- DOI
- 10.1101/745943
